ASO Visual Abstract: Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study

被引：0
|
作者：
Nobuhiro Nakazawa
Makoto Sohda
Yasunari Ubukata
Kengo Kuriyama
Akiharu Kimura
Norimichi Kogure
Hisashi Hosaka
Atsushi Naganuma
Masanori Sekiguchi
Kana Saito
Kyoichi Ogata
Akihiko Sano
Makoto Sakai
Hiroomi Ogawa
Ken Shirabe
Hiroshi Saeki
机构：
[1] Gunma University,Department of General Surgical Science, Graduate School of Medicine
[2] Gunma Prefectural Cancer Center,Department of Gastroenterology
[3] National Hospital Organization Takasaki General Medical Center,Department of Gastroenterology
[4] Isesaki Municipal Hospital,Department of Gastroenterology
[5] Japan Community Healthcare Organization Gunma Central Hospital,Department of Surgery
来源：
Annals of Surgical Oncology | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7409 / 7409
相关论文
共 30 条
  • [1] ASO Visual Abstract: Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study
    Nakazawa, Nobuhiro
    Sohda, Makoto
    Ubukata, Yasunari
    Kuriyama, Kengo
    Kimura, Akiharu
    Kogure, Norimichi
    Hosaka, Hisashi
    Naganuma, Atsushi
    Sekiguchi, Masanori
    Saito, Kana
    Ogata, Kyoichi
    Sano, Akihiko
    Sakai, Makoto
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (12) : 7409 - 7409
  • [2] ASO Author Reflections: Changes in the Gustave Roussy Immune Score is an Important Biomarker for Therapeutic Sensitivity of Nivolumab in Gastric Cancer
    Nobuhiro Nakazawa
    Akihiko Sano
    Makoto Sohda
    Ken Shirabe
    Hiroshi Saeki
    Annals of Surgical Oncology, 2022, 29 : 7407 - 7408
  • [3] ASO Author Reflections: Changes in the Gustave Roussy Immune Score is an Important Biomarker for Therapeutic Sensitivity of Nivolumab in Gastric Cancer
    Nakazawa, Nobuhiro
    Sano, Akihiko
    Sohda, Makoto
    Shirabe, Ken
    Saeki, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (12) : 7407 - 7408
  • [4] The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients
    Nakazawa, Nobuhiro
    Sohda, Makoto
    Endo, Mizuki
    Hosoi, Nobuhiro
    Uchida, Shintaro
    Watanabe, Takayoshi
    Sano, Akihiko
    Sakai, Makoto
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 94 (04) : 517 - 522
  • [5] Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study
    Jian, Shangguan
    Huang, Xinyi
    Liu, Xu
    Zhang, Zengfu
    Zhang, Xiaodong
    Yu, Jinming
    Chen, Dawei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study
    Nakazawa, Nobuhiro
    Sohda, Makoto
    Hosoi, Nobuhiro
    Watanabe, Takayoshi
    Kumakura, Yuji
    Yamashita, Toshiki
    Tanaka, Naritaka
    Saito, Kana
    Kimura, Akiharu
    Kasuga, Kengo
    Nakazato, Kenji
    Yoshinari, Daisuke
    Shimizu, Hisashi
    Ubukata, Yasunari
    Hosaka, Hisashi
    Sano, Akihiko
    Sakai, Makoto
    Ogawa, Hiroomi
    Shirabe, Ken
    Saeki, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (13) : 9023 - 9029
  • [7] The Gustave Roussy Immune score (GRIm score) as a novel prognostic score for early breast cancer patients: A real-world retrospective study
    Tan, Chunlei
    Xu, Jinling
    Yang, Xiaotian
    Wu, Danping
    Zhang, Shiyuan
    Liu, Shuqiang
    Yu, Boqian
    Huang, Yuanxi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (14): : 2640 - 2654
  • [8] Gustave Roussy Immune Score (GRIm-Score) Predicts Prognosis in Non-Small Cell Lung Cancer Patients Undergoing Nivolumab: A Multicenter Retrospective Study from Turkiye
    Majidova, Nargiz
    Yildirim, Sedat
    Kocaaslan, Erkam
    Guren, Ali Kaan
    Yildiz, Hacer Sahika
    Kircali, Muhammed Fatih
    Seyyar, Mustafa
    Sever, Nadiye
    Turan, Nedim
    Bayoglu, Ibrahim Vedat
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (04): : 206 - 212
  • [9] ASO Author Reflections: The Gustave Roussy Immune Score May Be a Useful Biomarker for Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Gastric Cancer
    Nakazawa, Nobuhiro
    Sano, Akihiko
    Sakai, Makoto
    Shirabe, Ken
    Saeki, Hiroshi
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (13) : 9052 - 9053
  • [10] Prognostic impact of immune-related adverse events with nivolumab in patients with advanced gastric cancer: A multicenter retrospective analysis
    Ohya, Yuno
    Ando, Takayuki
    Ueda, Akira
    Ogawa, Kohei
    Motoo, Iori
    Kajiura, Shinya
    Tsukada, Kenichiro
    Hara, Takuo
    Suzuki, Nobuhiro
    Nakada, Naokatsu
    Takatori, Shunsuke
    Horikawa, Naoki
    Fujii, Tsutomu
    Yasuda, Ichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
123